Tenet Healthcare (THC)
(Real Time Quote from BATS)
$98.08 USD
+0.22 (0.23%)
Updated Apr 24, 2024 10:56 AM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Tenet Healthcare Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 20,548 | 19,174 | 19,485 | 17,640 | 18,479 |
Cost Of Goods | 12,736 | 12,117 | 12,206 | 11,400 | 11,761 |
Gross Profit | 7,812 | 7,057 | 7,279 | 6,240 | 6,718 |
Selling & Adminstrative & Depr. & Amort Expenses | 5,302 | 4,724 | 4,408 | 4,251 | 5,205 |
Income After Depreciation & Amortization | 2,510 | 2,333 | 2,871 | 1,989 | 1,513 |
Non-Operating Income | 8 | -99 | -60 | -315 | -232 |
Interest Expense | 901 | 890 | 923 | 1,003 | 985 |
Pretax Income | 1,617 | 1,344 | 1,888 | 671 | 296 |
Income Taxes | 306 | 344 | 411 | -97 | 153 |
Minority Interest | 700 | 590 | 562 | 369 | 386 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,311 | 1,000 | 1,477 | 768 | 143 |
Extras & Discontinued Operations | 0 | 1 | -1 | 0 | 11 |
Net Income (GAAP) | 611 | 411 | 914 | 399 | -232 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 3,412 | 3,207 | 3,759 | 2,884 | 2,398 |
Depreciation & Amortization (Cash Flow) | 902 | 874 | 888 | 895 | 885 |
Income After Depreciation & Amortization | 2,510 | 2,333 | 2,871 | 1,989 | 1,513 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 104.80 | 110.52 | 108.57 | 106.26 | 103.40 |
Diluted EPS Before Non-Recurring Items | 6.98 | 6.80 | 7.58 | 4.73 | 2.68 |
Diluted Net EPS (GAAP) | 5.71 | 3.79 | 8.42 | 3.75 | -2.24 |
Fiscal Year end for Tenet Healthcare Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 5,379.00 | 5,066.00 | 5,082.00 | 5,021.00 |
Cost Of Goods | NA | 3,246.00 | 3,165.00 | 3,176.00 | 3,149.00 |
Gross Profit | NA | 2,133.00 | 1,901.00 | 1,906.00 | 1,872.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,398.00 | 1,333.00 | 1,302.00 | 1,269.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 735.00 | 568.00 | 604.00 | 603.00 |
Non-Operating Income | NA | 11.00 | 4.00 | -5.00 | -2.00 |
Interest Expense | NA | 227.00 | 227.00 | 226.00 | 221.00 |
Pretax Income | NA | 519.00 | 345.00 | 373.00 | 380.00 |
Income Taxes | NA | 63.00 | 79.00 | 80.00 | 84.00 |
Minority Interest | NA | 212.00 | 165.00 | 170.00 | 153.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 456.00 | 266.00 | 293.00 | 296.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 244.00 | 101.00 | 123.00 | 143.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 104.17 | 104.43 | 104.78 | 106.01 |
Diluted EPS Before Non-Recurring Items | NA | 2.68 | 1.44 | 1.44 | 1.42 |
Diluted Net EPS (GAAP) | NA | 2.30 | 0.94 | 1.15 | 1.32 |